Related references
Note: Only part of the references are listed.Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States
Allison M. Liddell et al.
ANNALS OF INTERNAL MEDICINE (2015)
Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease
Diana F. Florescu et al.
CLINICAL INFECTIOUS DISEASES (2015)
Clinical Features of Patients With Ebola Virus Disease in Sierra Leone
Enqiang Qin et al.
CLINICAL INFECTIOUS DISEASES (2015)
Clinical Predictors of Mortality in Patients With Ebola Virus Disease
Moumie Barry et al.
CLINICAL INFECTIOUS DISEASES (2015)
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
Colleen S. Kraft et al.
CLINICAL INFECTIOUS DISEASES (2015)
The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Medecins Sans Frontieres Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014
Gabriel Fitzpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care
Timo Wolf et al.
LANCET (2015)
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates
Emily P. Thi et al.
NATURE (2015)
Ebola Virus Disease among Children in West Africa
Junerlyn Agua-Agum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea
Elhadj Ibrahima Bah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Characterization of Clinical and Immunological Parameters During Ebola Virus Infection of Rhesus Macaques
Karen Martins et al.
VIRAL IMMUNOLOGY (2015)
Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
Ben S. Cooper et al.
PLOS MEDICINE (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Randomised controlled trials for Ebola: practical and ethical issues
Clement Adebamowo et al.
LANCET (2014)
Ebola Virus Disease in West Africa - The First 9 Months of the Epidemic and Forward Projections
Bruce Aylward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
J. S. Schieffelin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ebola Virus Disease in West Africa - Clinical Manifestations and Management
Daniel S. Chertow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Animal models for Ebola and Marburg virus infections
Eri Nakayama et al.
FRONTIERS IN MICROBIOLOGY (2013)
Basic Clinical and Laboratory Features of Filoviral Hemorrhagic Fever
Mark G. Kortepeter et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Short Report: Comprehensive Panel of Real-Time TaqMan™ Polymerase Chain Reaction Assays for Detection and Absolute Quantification of Filoviruses, Arenaviruses, and New World Hantaviruses
Adrienne R. Trombley et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
Thomas W. Geisbert et al.
LANCET (2010)
An exact method for analysis following a two-stage phase II cancer clinical trial
Gordana Jovic et al.
STATISTICS IN MEDICINE (2010)
Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome
JS Towner et al.
JOURNAL OF VIROLOGY (2004)
Pathogenesis of filoviral haemorrhagic fevers
S Mahanty et al.
LANCET INFECTIOUS DISEASES (2004)
Stopping clinical trials because of treatment ineffectiveness:: a comparison of a futility design with a method of stochastic curtailment
J Whitehead et al.
STATISTICS IN MEDICINE (2003)
The pathogenesis of Ebola hemorrhagic fever
A Takada et al.
TRENDS IN MICROBIOLOGY (2001)
Share Paper
